IRMD insider buying and SEC filings, explained
Iradimed Corp. · CIK 1325618
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$3.4M
Planned sales (10b5-1)
$15.4M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 3, 2026 | Sale | Monty K. Allen (Director) sold 1,419 shares at about $86.41 ($123K). Holdings down 7% to 19,581 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 8, 2026 |
| Jun 4, 2026 | Sale | Hilda Frederique Scharen-Guivel (Director) sold 3,000 shares at $95.00 ($285K). Holdings down 35% to 5,598 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 4, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 2,500 shares indirectly (by trust) at about $90.60 ($227K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,162,500 shares. | SEC filing Filed Jun 2, 2026 |
| May 26–27, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) between May 26 and May 27 at about $92.14 ($691K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,165,000 shares. | SEC filing Filed May 28, 2026 |
| May 18–19, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) between May 18 and May 19 at about $87.64 ($657K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,172,500 shares. | SEC filing Filed May 20, 2026 |
| May 11–12, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) between May 11 and May 12 at about $84.18 ($631K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,180,000 shares. | SEC filing Filed May 13, 2026 |
| May 4–5, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) between May 4 and May 5 at about $85.71 ($643K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,187,500 shares. | SEC filing Filed May 6, 2026 |
| Apr 27–28, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) between Apr 27 and Apr 28 at about $87.69 ($658K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,195,000 shares. | SEC filing Filed Apr 30, 2026 |
| Apr 20–21, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) between Apr 20 and Apr 21 at about $92.55 ($694K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,202,500 shares. | SEC filing Filed Apr 22, 2026 |
| Apr 13–14, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) between Apr 13 and Apr 14 at about $92.96 ($697K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,210,000 shares. | SEC filing Filed Apr 15, 2026 |
| Apr 6–7, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) between Apr 6 and Apr 7 at about $95.63 ($717K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,217,500 shares. | SEC filing Filed Apr 7, 2026 |
| Mar 30, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) at about $95.02 ($713K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,225,000 shares. | SEC filing Filed Apr 1, 2026 |
| Mar 23–24, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) between Mar 23 and Mar 24 at about $100.35 ($753K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,232,500 shares. | SEC filing Filed Mar 25, 2026 |
| Mar 16–17, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) between Mar 16 and Mar 17 at about $101.73 ($763K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,240,000 shares. | SEC filing Filed Mar 18, 2026 |
| Mar 9–10, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) between Mar 9 and Mar 10 at about $100.06 ($750K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,247,500 shares. | SEC filing Filed Mar 10, 2026 |
| Mar 6, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 7,500 shares indirectly (by trust) at about $98.39 ($738K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,255,000 shares. | SEC filing Filed Mar 9, 2026 |
| Feb 13, 2026 | Sale | Monty K. Allen (Director) sold 1,000 shares at about $100.26 ($100K). Holdings down 5% to 21,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 13, 2026 |
| Jan 26, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $100.65 ($503K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,262,500 shares. | SEC filing Filed Jan 27, 2026 |
| Jan 20, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $101.84 ($509K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,267,500 shares. | SEC filing Filed Jan 21, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $97.45 ($487K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,272,500 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 5, 2026 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $97.68 ($488K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,277,500 shares. | SEC filing Filed Jan 6, 2026 |
| Dec 29, 2025 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $97.66 ($488K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,282,500 shares. | SEC filing Filed Dec 30, 2025 |
| Dec 22, 2025 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $96.73 ($484K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,287,500 shares. | SEC filing Filed Dec 22, 2025 |
| Dec 15, 2025 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $96.75 ($484K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,292,500 shares. | SEC filing Filed Dec 17, 2025 |
| Dec 11, 2025 | Sale | John Glenn (CFO) sold 15,000 shares at about $97.29 ($1.5M). Holdings down 67% to 7,362 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 12, 2025 |
| Dec 9, 2025 | Sale | James B. Hawkins (Director) sold 3,000 shares at about $96.61 ($290K). Holdings down 9% to 28,742 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 10, 2025 |
| Dec 8, 2025 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $95.43 ($477K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,297,500 shares. | SEC filing Filed Dec 9, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $92.76 ($464K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,302,500 shares. | SEC filing Filed Dec 2, 2025 |
| Nov 24, 2025 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $90.36 ($452K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,307,500 shares. | SEC filing Filed Nov 24, 2025 |
| Nov 20, 2025 | Sale | James B. Hawkins (Director) sold 3,000 shares at about $88.24 ($265K). Holdings down 9% to 30,545 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 21, 2025 |
| Nov 18, 2025 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $85.59 ($428K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,312,500 shares. | SEC filing Filed Nov 19, 2025 |
| Nov 10, 2025 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $85.24 ($426K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,317,500 shares. | SEC filing Filed Nov 12, 2025 |
| Nov 10, 2025 | Sale | John Glenn (CFO) sold 10,651 shares at about $84.51 ($900K). Holdings down 81% to 2,500 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 12, 2025 |
| Nov 3, 2025 | Planned (10b5-1) | Roger E. Susi (CEO and Director) sold 5,000 shares indirectly (by trust) at about $82.64 ($413K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 2,322,500 shares. | SEC filing Filed Nov 4, 2025 |
16 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Oct 30, 2026, 8:37 AM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow IRMD in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.